VYGR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $267,185.66

Voyager Therapeutics Insider Trading History Chart

Voyager Therapeutics Share Price & Price History

^$7.61

▲ +0.19 (2.56%)

As of 04/26/2024 04:07 PM ET

Days: 30 | 90 | 365

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

Voyager Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/17/2024	Robin Swartz	COO	Sell	2,543	$7.15	$18,182.45	72,327
1/17/2024	Todd Alfred Carter	Insider	Sell	1,266	$7.18	$9,089.88	53,094
10/3/2023	Peter P Pfreundschuh	CFO	Sell	13,567	$6.99	$94,833.33	149,433
9/15/2023	Todd Alfred Carter	Insider	Sell	10,500	$8.16	$85,680.00	54,360
7/6/2023	Todd Alfred Carter	Insider	Sell	5,500	$10.80	$59,400.00	59,860
4/3/2023	Alfred Sandrock	CEO	Sell	7,437	$7.83	$58,231.71	214,618
4/3/2023	Robin Swartz	COO	Sell	1,259	$7.83	$9,857.97	71,617
3/20/2023	Robert W Hesslein	VP	Sell	4,410	$7.76	$34,221.60	102,200
3/20/2023	Robin Swartz	COO	Sell	3,654	$7.76	$28,355.04	72,876
3/20/2023	Todd Alfred Carter	Insider	Sell	2,193	$7.76	$17,017.68	65,360
2/23/2023	Neurocrine Biosciences Inc	Major Shareholder	Buy	4,395,588	$8.88	$39,032,821.44	8,575,316
2/17/2023	Robert W Hesslein	VP	Sell	3,297	$7.45	$24,562.65	106,610
2/17/2023	Todd Alfred Carter	Insider	Sell	738	$7.45	$5,498.10	67,553
2/13/2023	Robert W Hesslein	VP	Sell	2,868	$7.67	$21,997.56	109,907
2/13/2023	Todd Alfred Carter	Insider	Sell	797	$7.67	$6,112.99	34,291
2/1/2023	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	128,642	$9.32	$1,198,943.44	4,685,291
1/30/2023	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	75,000	$9.03	$677,250.00	4,998,933
1/27/2023	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	50,000	$9.02	$451,000.00	5,073,933
1/25/2023	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	50,000	$9.22	$461,000.00	5,123,933
1/23/2023	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	55,000	$9.06	$498,300.00	5,273,933
1/20/2023	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	100,000	$9.15	$915,000.00	5,328,933
1/17/2023	Robert W Hesslein	VP	Sell	2,188	$9.85	$21,551.80	112,775
1/17/2023	Todd Alfred Carter	Insider	Sell	1,106	$9.85	$10,894.10	35,088
1/11/2023	Ecor1 Capital, Llc	Major Shareholder	Sell	110,000	$8.50	$935,000.00	3,851,507
1/9/2023	Ecor1 Capital, Llc	Major Shareholder	Sell	456,000	$7.67	$3,497,520.00	4,297,907
8/24/2022	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	149,972	$6.09	$913,329.48	5,628,933
8/15/2022	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	135,808	$6.04	$820,280.32	5,907,361
8/12/2022	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	348,007	$6.12	$2,129,802.84	6,043,169
7/14/2022	Glenn Pierce	Director	Sell	9,512	$6.70	$63,730.40	16,788
6/23/2022	Ecor1 Capital, Llc	Major Shareholder	Buy	376,000	$5.66	$2,128,160.00	4,753,907
6/21/2022	Ecor1 Capital, Llc	Major Shareholder	Buy	101,400	$5.28	$535,392.00	4,377,907
4/4/2022	Robert W Hesslein	VP	Sell	2,786	$8.25	$22,984.50	114,963
4/4/2022	Robin Swartz	COO	Sell	1,527	$8.25	$12,597.75	52,060
3/21/2022	Robert W Hesslein	VP	Sell	4,955	$8.29	$41,076.95
3/21/2022	Robin Swartz	COO	Sell	4,413	$8.29	$36,583.77
2/11/2022	Robert W Hesslein	VP	Sell	3,252	$3.36	$10,926.72
1/12/2022	Julie Burek	VP	Sell	265	$3.06	$810.90
1/3/2022	Julie Burek	VP	Sell	3,063	$2.83	$8,668.29

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

SEC Filings (Institutional Ownership Changes) for Voyager Therapeutics (NASDAQ:VYGR)

48.03% of Voyager Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Voyager Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/24/2024	Assenagon Asset Management S.A.	28,896	$0.27M	0.0%	+60.9%	0.053%
4/23/2024	Hunter Perkins Capital Management LLC	65,165	$0.61M	0.1%	N/A	0.120%
4/18/2024	Allspring Global Investments Holdings LLC	99,306	$0.93M	0.0%	+2.1%	0.183%
2/14/2024	ADAR1 Capital Management LLC	185,894	$1.57M	0.6%	N/A	0.423%
2/13/2024	Tower Research Capital LLC TRC	6,399	$54K	0.0%	+302.5%	0.015%
2/13/2024	Armistice Capital LLC	4,236,000	$35.75M	0.5%	+1.4%	9.629%
2/8/2024	Massachusetts Financial Services Co. MA	110,926	$0.94M	0.0%	-3.1%	0.252%
2/6/2024	AJOVista LLC	4,573	$39K	0.0%	N/A	0.010%
2/5/2024	SummerHaven Investment Management LLC	74,146	$0.63M	0.4%	+1.9%	0.169%
1/31/2024	Federated Hermes Inc.	551,576	$4.66M	0.0%	-5.5%	1.254%
1/30/2024	Cornercap Investment Counsel Inc.	23,217	$0.20M	0.0%	N/A	0.053%
1/25/2024	Allspring Global Investments Holdings LLC	97,276	$0.82M	0.0%	+27.4%	0.221%
1/24/2024	China Universal Asset Management Co. Ltd.	5,093	$43K	0.0%	N/A	0.012%
1/18/2024	Ritholtz Wealth Management	19,759	$0.17M	0.0%	+11.8%	0.045%
1/17/2024	Assenagon Asset Management S.A.	17,960	$0.15M	0.0%	-47.4%	0.041%
1/16/2024	Raymond James Financial Services Advisors Inc.	28,802	$0.24M	0.0%	-5.8%	0.065%
12/18/2023	Gladius Capital Management LP	3,182	$25K	0.0%	N/A	0.007%
12/18/2023	Vanguard Group Inc.	2,481,957	$19.24M	0.0%	+0.2%	5.642%
11/15/2023	Alps Advisors Inc.	37,900	$0.29M	0.0%	N/A	0.086%
11/15/2023	Armistice Capital LLC	4,178,000	$32.38M	0.5%	+15.3%	9.498%
11/14/2023	O Shaughnessy Asset Management LLC	51,690	$0.40M	0.0%	+131.2%	0.118%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	36,425	$0.28M	0.0%	-67.2%	0.083%
11/13/2023	Federated Hermes Inc.	583,885	$4.53M	0.0%	-0.7%	1.327%
11/13/2023	Acadian Asset Management LLC	630,163	$4.88M	0.0%	-12.4%	1.432%
11/13/2023	Silverarc Capital Management LLC	103,966	$0.81M	0.2%	+4.0%	0.236%
11/13/2023	Aigen Investment Management LP	14,063	$0.11M	0.0%	N/A	0.032%
11/13/2023	WINTON GROUP Ltd	49,626	$0.39M	0.0%	+103.9%	0.113%
11/13/2023	Kestra Advisory Services LLC	126,483	$0.98M	0.0%	N/A	0.287%
11/9/2023	Deutsche Bank AG	64,832	$0.50M	0.0%	-4.6%	0.148%
11/8/2023	Massachusetts Financial Services Co. MA	114,431	$0.89M	0.0%	N/A	0.261%
11/8/2023	Hussman Strategic Advisors Inc.	52,500	$0.41M	0.1%	N/A	0.120%
11/7/2023	Barclays PLC	18,309	$0.14M	0.0%	+188.8%	0.042%
11/7/2023	Ascension Capital Advisors Inc.	14,500	$0.11M	0.1%	N/A	0.033%
11/6/2023	Assenagon Asset Management S.A.	34,159	$0.27M	0.0%	-82.9%	0.078%
10/27/2023	Allspring Global Investments Holdings LLC	76,360	$0.59M	0.0%	N/A	0.174%
10/27/2023	TD Asset Management Inc	133,502	$1.04M	0.0%	+100.0%	0.304%
10/26/2023	Inspire Investing LLC	82,656	$0.64M	0.1%	N/A	0.188%
10/26/2023	Strs Ohio	18,600	$0.14M	0.0%	-36.5%	0.042%
10/24/2023	Bank of New York Mellon Corp	192,869	$1.50M	0.0%	+0.8%	0.439%
10/13/2023	SummerHaven Investment Management LLC	72,779	$0.56M	0.4%	N/A	0.166%
10/13/2023	Ritholtz Wealth Management	17,670	$0.14M	0.0%	N/A	0.040%
10/10/2023	Gladius Capital Management LP	3,182	$25K	0.0%	N/A	0.007%
9/21/2023	Barclays PLC	6,339	$72K	0.0%	-82.1%	0.014%
8/15/2023	Silverarc Capital Management LLC	100,000	$1.15M	0.4%	N/A	0.228%
8/14/2023	State of Wyoming	34,073	$0.39M	0.1%	N/A	0.078%
8/14/2023	WINTON GROUP Ltd	24,342	$0.28M	0.0%	N/A	0.055%
8/11/2023	Campbell & CO Investment Adviser LLC	36,994	$0.42M	0.1%	+21.0%	0.084%
8/11/2023	O Shaughnessy Asset Management LLC	22,359	$0.26M	0.0%	N/A	0.051%
8/11/2023	Trexquant Investment LP	44,252	$0.51M	0.0%	N/A	0.101%
8/10/2023	Bessemer Group Inc.	3,513	$40K	0.0%	-91.0%	0.008%
8/9/2023	TD Asset Management Inc	66,751	$0.76M	0.0%	+22.9%	0.152%
8/7/2023	Acadian Asset Management LLC	719,659	$8.24M	0.0%	-3.1%	1.639%
8/4/2023	American International Group Inc.	15,287	$0.18M	0.0%	N/A	0.035%
8/3/2023	Bank of New York Mellon Corp	191,414	$2.19M	0.0%	+94.4%	0.440%
8/1/2023	Fiduciary Trust Co.	255,560	$2.93M	0.1%	+1.3%	0.587%
7/31/2023	Strs Ohio	29,300	$0.34M	0.0%	N/A	0.067%
7/27/2023	Virtu Financial LLC	27,855	$0.32M	0.0%	N/A	0.064%
7/25/2023	Assenagon Asset Management S.A.	199,492	$2.28M	0.0%	+76.3%	0.458%
7/18/2023	Denali Advisors LLC	15,300	$0.18M	0.1%	N/A	0.035%
5/16/2023	Armistice Capital LLC	3,524,000	$27.17M	0.4%	+3.8%	8.094%
5/15/2023	EcoR1 Capital LLC	3,851,507	$29.70M	1.0%	-19.0%	8.851%
5/15/2023	HarbourVest Partners LLC	61,776	$0.48M	0.2%	N/A	0.142%
5/15/2023	Farallon Capital Management LLC	797,000	$6.15M	0.0%	N/A	1.832%
5/15/2023	Globeflex Capital L P	36,109	$0.28M	0.0%	N/A	0.083%
5/12/2023	Hershey Trust Co.	12,580	$97K	0.0%	N/A	0.029%
5/11/2023	Acadian Asset Management LLC	742,355	$5.72M	0.0%	+11.0%	1.706%
5/10/2023	Bessemer Group Inc.	38,987	$0.30M	0.0%	N/A	0.090%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	110,818	$0.85M	0.0%	-4.8%	0.255%
5/3/2023	Jump Financial LLC	16,300	$0.13M	0.0%	+55.5%	0.038%
4/24/2023	DekaBank Deutsche Girozentrale	50,000	$0.38M	0.0%	N/A	0.116%
4/18/2023	Assenagon Asset Management S.A.	113,165	$0.87M	0.0%	N/A	0.261%
4/14/2023	Raymond James Financial Services Advisors Inc.	31,252	$0.24M	0.0%	-14.6%	0.072%
2/14/2023	683 Capital Management LLC	31,388	$0.19M	0.0%	N/A	0.081%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	116,405	$0.71M	0.0%	+3.8%	0.302%
2/9/2023	Citigroup Inc.	84,033	$0.51M	0.0%	+2,458.9%	0.218%
2/8/2023	Raymond James & Associates	109,910	$0.67M	0.0%	N/A	0.285%
11/15/2022	Federated Hermes Inc.	605,795	$3.59M	0.0%	-1.2%	1.569%
11/14/2022	Armistice Capital LLC	3,396,000	$20.10M	0.3%	+32.4%	8.796%
11/14/2022	Point72 Asset Management L.P.	289,420	$1.71M	0.0%	N/A	0.750%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	112,155	$0.66M	0.0%	-6.7%	0.290%
11/10/2022	Hillsdale Investment Management Inc.	87,967	$0.52M	0.0%	+347.3%	0.228%
11/7/2022	Jump Financial LLC	26,000	$0.15M	0.0%	-27.3%	0.067%
11/3/2022	TRV GP Iii LLC	5,428,933	$32.14M	14.0%	-15.1%	14.047%
10/27/2022	Assenagon Asset Management S.A.	16,224	$96K	0.0%	-17.8%	0.042%
10/25/2022	Raymond James Financial Services Advisors Inc.	37,788	$0.22M	0.0%	+11.6%	0.098%
10/18/2022	Bailard Inc.	28,900	$0.17M	0.0%	N/A	0.075%
9/16/2022	Federated Hermes Inc.	613,047	$3.62M	0.0%	-1.9%	1.586%
8/9/2022	Lazard Asset Management LLC	10,283	$60K	0.0%	-41.8%	0.027%
8/8/2022	Walleye Capital LLC	38,906	$0.23M	0.0%	-74.2%	0.101%
8/5/2022	Landscape Capital Management L.L.C.	16,306	$96K	0.0%	N/A	0.042%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	120,231	$0.71M	0.0%	-10.0%	0.313%
8/4/2022	TD Asset Management Inc.	54,300	$0.32M	0.0%	N/A	0.141%
7/27/2022	Assenagon Asset Management S.A.	19,741	$0.12M	0.0%	N/A	0.051%
7/21/2022	Belvedere Trading LLC	26,432	$0.18M	0.0%	-27.3%	0.069%
7/19/2022	Commonwealth Equity Services LLC	24,334	$0.14M	0.0%	N/A	0.063%
7/19/2022	Harvest Investment Services LLC	42,312	$0.25M	0.2%	N/A	0.110%
5/27/2022	Walleye Capital LLC	150,667	$1.15M	0.0%	N/A	0.392%
5/12/2022	Acadian Asset Management LLC	247,970	$1.89M	0.0%	-54.8%	0.645%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	133,572	$1.02M	0.0%	-9.5%	0.347%
5/6/2022	Koss Olinger Consulting LLC	17,636	$0.13M	0.0%	-10.8%	0.046%

Data available starting January 2016

Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company's lead clinical candidate is VY-TAU01, an anti-tau antibody program for the treatment of alzheimer's disease. Its product pipeline includes superoxide dismutase 1 silencing gene therapy, which is in preclinical trial for the treatment of amyotrophic lateral sclerosis; tau silencing gene therapy, which is in preclinical trial for the treatment of alzheimer's disease; and vectorized anti-amyloid antibody, a gene therapy targeting anti-amyloid for the treatment of alzheimer's disease and is in preclinical trial. In addition, the company develops VY-FXN01, which is in preclinical trial to treat friedreich's ataxia; and GBA1 gene replacement to treat parkinson's disease and is in preclinical trial. Further, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc; and Sangamo Therapeutics, Inc. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.

Today's Range

Now: $7.61

$7.32

$7.71

50 Day Range

MA: $8.80

$7.42

$10.54

52 Week Range

Now: $7.61

$6.06

$14.34

Volume

178,489 shs

Average Volume

895,360 shs

Market Capitalization

$413.22 million

P/E Ratio

2.46

Dividend Yield

N/A

Beta

0.96

Who are the company insiders with the largest holdings of Voyager Therapeutics?: Voyager Therapeutics' top insider investors include:
Neurocrine Biosciences Inc (Major Shareholder)
Rock Ventures Iii LP Third (Major Shareholder)
Ecor1 Capital, Llc (Major Shareholder)
Alfred Sandrock (CEO)
Peter P Pfreundschuh (CFO)
Robert W Hesslein (VP)
Robin Swartz (COO)
Todd Alfred Carter (Insider)
Glenn Pierce (Director)
Learn More about top insider investors at Voyager Therapeutics.
Who are the major institutional investors of Voyager Therapeutics?: Voyager Therapeutics' top institutional shareholders include:
Allspring Global Investments Holdings LLC — 0.18%
Hunter Perkins Capital Management LLC — 0.12%
Assenagon Asset Management S.A. — 0.05%
Learn More about top institutional investors of Voyager Therapeutics stock.
Which major investors are buying Voyager Therapeutics stock?: In the previous quarter, VYGR stock was bought by institutional investors including:
Hunter Perkins Capital Management LLC
Assenagon Asset Management S.A.
Allspring Global Investments Holdings LLC
During the last year, these company insiders have bought Voyager Therapeutics stock:
Neurocrine Biosciences Inc (Major Shareholder)
Rock Ventures Iii LP Third (Major Shareholder)
Learn More investors buying Voyager Therapeutics stock.